I want to see 30, but I also want my wife to be convinced right now that I am wise biotech stock picker, or else she would stop lending me money to cover my margin calls.
Anyway, if nothing happens to China, Greece, or Russia, I see $6-7 at least by the 2nd week of June.
One more manipulation downward before pps is allowed to run up to $5-6 the last week of April. Maybe.
Five of Six Evaluable Patients with TRK Fusion Cancers Achieve Confirmed RECIST Partial Responses; All Six Demonstrate Significant Tumor Regressions –
– All TRK Fusion Patients Remain on Study, With Longest Follow-up Beyond One Year
ARRY pipeline is more impressive, yet LOXO has higher market cap.
Street knows how to make money which ever way they can. Street pulling this down today and loading up and will probably drive this back up tomorrow or the next day to 4.50 or higher.
IFN-gamma and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma, Cancer Discovery (2016).
I agree. But as long as there are shorts who can walk this down on low volume, this will keep going down until the big news comes, whether it be from Gabriel, Apple settles, or buyout happens. I am waiting on the sidelines before I add more.
He sold a little more than the jury award to VirnetX. He probably bought shares of VHC with his AAPL proceeds.